Fundies.
English

Segment disclosures

Company overview

Fortrea Holdings Inc.

Each reported dimension combination stays separate. Revenue and operating income are shown as reported, with their dates and sources.

Revenue · Reported segment facts

19 dimension combinations 151 retained observations 18 reported periods

Counts describe retained dimensioned rows only. Periods and members can change across reports, and this view does not infer missing values or expected segment totals.

Intersegment Elimination · Clinical Services Segment

Consolidation Items · Statement Business Segments

Source dimensions srt:ConsolidationItemsAxis=us-gaap:IntersegmentEliminationMember;us-gaap:StatementBusinessSegmentsAxis=ftre:ClinicalServicesSegmentMember
PeriodValueUnitFiledEvidence
2023-07-01 – 2023-09-30-300000 USD20231113Open filing evidence
2023-01-01 – 2023-09-30-900000 USD20231113Open filing evidence
2022-07-01 – 2022-09-30-300000 USD20231113Open filing evidence
2022-01-01 – 2022-09-30-800000 USD20231113Open filing evidence

Intersegment Elimination · Enabling Services Segment

Consolidation Items · Statement Business Segments

Source dimensions srt:ConsolidationItemsAxis=us-gaap:IntersegmentEliminationMember;us-gaap:StatementBusinessSegmentsAxis=ftre:EnablingServicesSegmentMember
PeriodValueUnitFiledEvidence
2023-07-01 – 2023-09-30-2500000 USD20231113Open filing evidence
2023-01-01 – 2023-09-30-6900000 USD20231113Open filing evidence
2023-04-01 – 2023-06-301400000 USD20230814Open filing evidence
2023-01-01 – 2023-06-304400000 USD20230814Open filing evidence
2022-07-01 – 2022-09-30-1800000 USD20231113Open filing evidence
2022-01-01 – 2022-09-30-7100000 USD20231113Open filing evidence
2022-04-01 – 2022-06-303200000 USD20230814Open filing evidence
2022-01-01 – 2022-06-305300000 USD20230814Open filing evidence

Operating Segments · Clinical Services Segment

Consolidation Items · Statement Business Segments

Source dimensions srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;us-gaap:StatementBusinessSegmentsAxis=ftre:ClinicalServicesSegmentMember
PeriodValueUnitFiledEvidence
2026-04-01 – 2026-06-30678200000 USD20260729Open filing evidence
2026-01-01 – 2026-06-301314700000 USD20260729Open filing evidence
2026-01-01 – 2026-03-31636500000 USD20260505Open filing evidence
2025-01-01 – 2025-12-312723400000 USD20260226Open filing evidence
2025-07-01 – 2025-09-30701300000 USD20251105Open filing evidence
2025-01-01 – 2025-09-302062900000 USD20251105Open filing evidence
2025-04-01 – 2025-06-30710300000 USD20260729Open filing evidence
2025-01-01 – 2025-06-301361600000 USD20260729Open filing evidence
2025-01-01 – 2025-03-31651300000 USD20260505Open filing evidence
2024-01-01 – 2024-12-312696400000 USD20260226Open filing evidence
2024-07-01 – 2024-09-30674900000 USD20251105Open filing evidence
2024-01-01 – 2024-09-301999400000 USD20251105Open filing evidence
2024-04-01 – 2024-06-30662400000 USD20250806Open filing evidence
2024-01-01 – 2024-06-301324500000 USD20250806Open filing evidence
2024-01-01 – 2024-03-31662100000 USD20250512Open filing evidence
2023-01-01 – 2023-12-312842500000 RestatedUSD20260226Open filing evidence
2023-07-01 – 2023-09-30711700000 USD20231113Open filing evidence
2023-01-01 – 2023-09-302129800000 USD20231113Open filing evidence
2023-04-01 – 2023-06-30726100000 USD20230814Open filing evidence
2023-01-01 – 2023-06-301418100000 USD20230814Open filing evidence
2022-01-01 – 2022-12-312837000000 RestatedUSD20250303Open filing evidence
2022-07-01 – 2022-09-30697200000 USD20231113Open filing evidence
2022-01-01 – 2022-09-302127600000 USD20231113Open filing evidence
2022-04-01 – 2022-06-30723300000 USD20230814Open filing evidence
2022-01-01 – 2022-06-301430400000 USD20230814Open filing evidence
2021-01-01 – 2021-12-312763500000 USD20240313Open filing evidence

Operating Segments · Enabling Services Segment

Consolidation Items · Statement Business Segments

Source dimensions srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;us-gaap:StatementBusinessSegmentsAxis=ftre:EnablingServicesSegmentMember
PeriodValueUnitFiledEvidence
2023-01-01 – 2023-12-31269500000 USD20240313Open filing evidence
2023-07-01 – 2023-09-3064700000 USD20231113Open filing evidence
2023-01-01 – 2023-09-30203800000 USD20231113Open filing evidence
2023-04-01 – 2023-06-3066900000 USD20230814Open filing evidence
2023-01-01 – 2023-06-30139100000 USD20230814Open filing evidence
2022-01-01 – 2022-12-31270700000 USD20240313Open filing evidence
2022-07-01 – 2022-09-3065100000 USD20231113Open filing evidence
2022-01-01 – 2022-09-30206800000 USD20231113Open filing evidence
2022-04-01 – 2022-06-3069800000 USD20230814Open filing evidence
2022-01-01 – 2022-06-30141700000 USD20230814Open filing evidence
2021-01-01 – 2021-12-31294000000 USD20240313Open filing evidence

Other Geographical Areas · Clinical Services Segment

Statement Geographical · Statement Business Segments

Source dimensions srt:StatementGeographicalAxis=ftre:OtherGeographicalAreasMember;us-gaap:StatementBusinessSegmentsAxis=ftre:ClinicalServicesSegmentMember
PeriodValueUnitFiledEvidence
2023-07-01 – 2023-09-30160000000 USD20231113Open filing evidence
2023-01-01 – 2023-09-30458500000 USD20231113Open filing evidence
2023-04-01 – 2023-06-30154400000 USD20230814Open filing evidence
2023-01-01 – 2023-06-30298500000 USD20230814Open filing evidence
2022-07-01 – 2022-09-30145900000 USD20231113Open filing evidence
2022-01-01 – 2022-09-30438000000 USD20231113Open filing evidence
2022-04-01 – 2022-06-30145700000 USD20230814Open filing evidence
2022-01-01 – 2022-06-30292100000 USD20230814Open filing evidence

Other Geographical Areas · Enabling Services Segment

Statement Geographical · Statement Business Segments

Source dimensions srt:StatementGeographicalAxis=ftre:OtherGeographicalAreasMember;us-gaap:StatementBusinessSegmentsAxis=ftre:EnablingServicesSegmentMember
PeriodValueUnitFiledEvidence
2023-04-01 – 2023-06-30400000 USD20230814Open filing evidence
2023-01-01 – 2023-06-30600000 USD20230814Open filing evidence
2022-04-01 – 2022-06-30600000 USD20230814Open filing evidence
2022-01-01 – 2022-06-301100000 USD20230814Open filing evidence

Europe · Clinical Services Segment

Statement Geographical · Statement Business Segments

Source dimensions srt:StatementGeographicalAxis=srt:EuropeMember;us-gaap:StatementBusinessSegmentsAxis=ftre:ClinicalServicesSegmentMember
PeriodValueUnitFiledEvidence
2023-01-01 – 2023-12-31827500000 USD20240313Open filing evidence
2023-07-01 – 2023-09-30204300000 USD20231113Open filing evidence
2023-01-01 – 2023-09-30600700000 USD20231113Open filing evidence
2023-04-01 – 2023-06-30200400000 USD20230814Open filing evidence
2023-01-01 – 2023-06-30396400000 USD20230814Open filing evidence
2022-01-01 – 2022-12-31841900000 USD20240313Open filing evidence
2022-07-01 – 2022-09-30196000000 USD20231113Open filing evidence
2022-01-01 – 2022-09-30642600000 USD20231113Open filing evidence
2022-04-01 – 2022-06-30224200000 USD20230814Open filing evidence
2022-01-01 – 2022-06-30446600000 USD20230814Open filing evidence
2021-01-01 – 2021-12-31868400000 USD20240313Open filing evidence

Europe · Enabling Services Segment

Statement Geographical · Statement Business Segments

Source dimensions srt:StatementGeographicalAxis=srt:EuropeMember;us-gaap:StatementBusinessSegmentsAxis=ftre:EnablingServicesSegmentMember
PeriodValueUnitFiledEvidence
2023-07-01 – 2023-09-300 USD20231113Open filing evidence
2023-01-01 – 2023-09-300 USD20231113Open filing evidence
2023-04-01 – 2023-06-300 USD20230814Open filing evidence
2023-01-01 – 2023-06-300 USD20230814Open filing evidence
2022-07-01 – 2022-09-300 USD20231113Open filing evidence
2022-01-01 – 2022-09-300 USD20231113Open filing evidence
2022-04-01 – 2022-06-300 USD20230814Open filing evidence
2022-01-01 – 2022-06-300 USD20230814Open filing evidence

North America · Clinical Services Segment

Statement Geographical · Statement Business Segments

Source dimensions srt:StatementGeographicalAxis=srt:NorthAmericaMember;us-gaap:StatementBusinessSegmentsAxis=ftre:ClinicalServicesSegmentMember
PeriodValueUnitFiledEvidence
2023-01-01 – 2023-12-311395400000 USD20240313Open filing evidence
2023-07-01 – 2023-09-30347400000 USD20231113Open filing evidence
2023-01-01 – 2023-09-301070600000 USD20231113Open filing evidence
2023-04-01 – 2023-06-30371300000 USD20230814Open filing evidence
2023-01-01 – 2023-06-30723200000 USD20230814Open filing evidence
2022-01-01 – 2022-12-311403900000 USD20240313Open filing evidence
2022-07-01 – 2022-09-30355300000 USD20231113Open filing evidence
2022-01-01 – 2022-09-301047000000 USD20231113Open filing evidence
2022-04-01 – 2022-06-30353400000 USD20230814Open filing evidence
2022-01-01 – 2022-06-30691700000 USD20230814Open filing evidence
2021-01-01 – 2021-12-311357600000 USD20240313Open filing evidence

North America · Enabling Services Segment

Statement Geographical · Statement Business Segments

Source dimensions srt:StatementGeographicalAxis=srt:NorthAmericaMember;us-gaap:StatementBusinessSegmentsAxis=ftre:EnablingServicesSegmentMember
PeriodValueUnitFiledEvidence
2023-07-01 – 2023-09-3064400000 USD20231113Open filing evidence
2023-01-01 – 2023-09-30202900000 USD20231113Open filing evidence
2023-04-01 – 2023-06-3066500000 USD20230814Open filing evidence
2023-01-01 – 2023-06-30138500000 USD20230814Open filing evidence
2022-07-01 – 2022-09-3064600000 USD20231113Open filing evidence
2022-01-01 – 2022-09-30205200000 USD20231113Open filing evidence
2022-04-01 – 2022-06-3069200000 USD20230814Open filing evidence
2022-01-01 – 2022-06-30140600000 USD20230814Open filing evidence

Clinical Services Segment

Statement Business Segments

Source dimensions us-gaap:StatementBusinessSegmentsAxis=ftre:ClinicalServicesSegmentMember
PeriodValueUnitFiledEvidence
2023-01-01 – 2023-12-312839500000 USD20240313Open filing evidence
2023-07-01 – 2023-09-30711700000 USD20231113Open filing evidence
2023-01-01 – 2023-09-302129800000 USD20231113Open filing evidence
2023-04-01 – 2023-06-30726100000 USD20230814Open filing evidence
2023-01-01 – 2023-06-301418100000 USD20230814Open filing evidence
2022-01-01 – 2022-12-312825400000 USD20240313Open filing evidence
2022-07-01 – 2022-09-30697200000 USD20231113Open filing evidence
2022-01-01 – 2022-09-302127600000 USD20231113Open filing evidence
2022-04-01 – 2022-06-30723300000 USD20230814Open filing evidence
2022-01-01 – 2022-06-301430400000 USD20230814Open filing evidence
2021-01-01 – 2021-12-312763500000 USD20240313Open filing evidence

Clinical Services Segment · Intersegment Elimination

Statement Business Segments · Consolidation Items

Source dimensions us-gaap:StatementBusinessSegmentsAxis=ftre:ClinicalServicesSegmentMember;srt:ConsolidationItemsAxis=us-gaap:IntersegmentEliminationMember
PeriodValueUnitFiledEvidence
2023-01-01 – 2023-12-31-1300000 USD20240313Open filing evidence
2023-04-01 – 2023-06-30300000 USD20230814Open filing evidence
2023-01-01 – 2023-06-30600000 USD20230814Open filing evidence
2022-01-01 – 2022-12-31-1300000 USD20240313Open filing evidence
2022-04-01 – 2022-06-30300000 USD20230814Open filing evidence
2022-01-01 – 2022-06-30500000 USD20230814Open filing evidence
2021-01-01 – 2021-12-31-300000 USD20240313Open filing evidence

Clinical Services Segment · Operating Segments

Statement Business Segments · Consolidation Items

Source dimensions us-gaap:StatementBusinessSegmentsAxis=ftre:ClinicalServicesSegmentMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember
PeriodValueUnitFiledEvidence
2026-07-01 – 2026-09-30691500000 USD2026-10-29 · 20:15:17.000ZOpen filing evidence
2026-01-01 – 2026-09-302006200000 USD2026-10-29 · 20:15:17.000ZOpen filing evidence
2025-07-01 – 2025-09-30701300000 USD2026-10-29 · 20:15:17.000ZOpen filing evidence
2025-01-01 – 2025-09-302062900000 USD2026-10-29 · 20:15:17.000ZOpen filing evidence

Clinical Services Segment · Other Geographical Areas

Statement Business Segments · Statement Geographical

Source dimensions us-gaap:StatementBusinessSegmentsAxis=ftre:ClinicalServicesSegmentMember;srt:StatementGeographicalAxis=ftre:OtherGeographicalAreasMember
PeriodValueUnitFiledEvidence
2023-01-01 – 2023-12-31616600000 USD20240313Open filing evidence
2022-01-01 – 2022-12-31579600000 USD20240313Open filing evidence
2021-01-01 – 2021-12-31537500000 USD20240313Open filing evidence

Enabling Services Segment

Statement Business Segments

Source dimensions us-gaap:StatementBusinessSegmentsAxis=ftre:EnablingServicesSegmentMember
PeriodValueUnitFiledEvidence
2023-01-01 – 2023-12-31269500000 USD20240313Open filing evidence
2023-07-01 – 2023-09-3064700000 USD20231113Open filing evidence
2023-01-01 – 2023-09-30203800000 USD20231113Open filing evidence
2023-04-01 – 2023-06-3066900000 USD20230814Open filing evidence
2023-01-01 – 2023-06-30139100000 USD20230814Open filing evidence
2022-01-01 – 2022-12-31270700000 USD20240313Open filing evidence
2022-07-01 – 2022-09-3065100000 USD20231113Open filing evidence
2022-01-01 – 2022-09-30206800000 USD20231113Open filing evidence
2022-04-01 – 2022-06-3069800000 USD20230814Open filing evidence
2022-01-01 – 2022-06-30141700000 USD20230814Open filing evidence
2021-01-01 – 2021-12-31294000000 USD20240313Open filing evidence

Enabling Services Segment · Intersegment Elimination

Statement Business Segments · Consolidation Items

Source dimensions us-gaap:StatementBusinessSegmentsAxis=ftre:EnablingServicesSegmentMember;srt:ConsolidationItemsAxis=us-gaap:IntersegmentEliminationMember
PeriodValueUnitFiledEvidence
2023-01-01 – 2023-12-31-8600000 USD20240313Open filing evidence
2022-01-01 – 2022-12-31-8300000 USD20240313Open filing evidence
2021-01-01 – 2021-12-31-10000000 USD20240313Open filing evidence

Enabling Services Segment · Other Geographical Areas

Statement Business Segments · Statement Geographical

Source dimensions us-gaap:StatementBusinessSegmentsAxis=ftre:EnablingServicesSegmentMember;srt:StatementGeographicalAxis=ftre:OtherGeographicalAreasMember
PeriodValueUnitFiledEvidence
2023-01-01 – 2023-12-311400000 USD20240313Open filing evidence
2023-07-01 – 2023-09-30300000 USD20231113Open filing evidence
2023-01-01 – 2023-09-30900000 USD20231113Open filing evidence
2022-01-01 – 2022-12-312100000 USD20240313Open filing evidence
2022-07-01 – 2022-09-30500000 USD20231113Open filing evidence
2022-01-01 – 2022-09-301600000 USD20231113Open filing evidence
2021-01-01 – 2021-12-312000000 USD20240313Open filing evidence

Enabling Services Segment · Europe

Statement Business Segments · Statement Geographical

Source dimensions us-gaap:StatementBusinessSegmentsAxis=ftre:EnablingServicesSegmentMember;srt:StatementGeographicalAxis=srt:EuropeMember
PeriodValueUnitFiledEvidence
2023-01-01 – 2023-12-310 USD20240313Open filing evidence
2022-01-01 – 2022-12-310 USD20240313Open filing evidence
2021-01-01 – 2021-12-310 USD20240313Open filing evidence

Enabling Services Segment · North America

Statement Business Segments · Statement Geographical

Source dimensions us-gaap:StatementBusinessSegmentsAxis=ftre:EnablingServicesSegmentMember;srt:StatementGeographicalAxis=srt:NorthAmericaMember
PeriodValueUnitFiledEvidence
2023-01-01 – 2023-12-31268100000 USD20240313Open filing evidence
2022-01-01 – 2022-12-31268600000 USD20240313Open filing evidence
2021-01-01 – 2021-12-31292000000 USD20240313Open filing evidence